Feldheim, J.; Wend, D.; Lauer, M.J.; Monoranu, C.M.; Glas, M.; Kleinschnitz, C.; Ernestus, R.-I.; Braunger, B.M.; Meybohm, P.; Hagemann, C.;
et al. Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients. Int. J. Mol. Sci. 2022, 23, 8101.
https://doi.org/10.3390/ijms23158101
AMA Style
Feldheim J, Wend D, Lauer MJ, Monoranu CM, Glas M, Kleinschnitz C, Ernestus R-I, Braunger BM, Meybohm P, Hagemann C,
et al. Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients. International Journal of Molecular Sciences. 2022; 23(15):8101.
https://doi.org/10.3390/ijms23158101
Chicago/Turabian Style
Feldheim, Jonas, David Wend, Mara J. Lauer, Camelia M. Monoranu, Martin Glas, Christoph Kleinschnitz, Ralf-Ingo Ernestus, Barbara M. Braunger, Patrick Meybohm, Carsten Hagemann,
and et al. 2022. "Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients" International Journal of Molecular Sciences 23, no. 15: 8101.
https://doi.org/10.3390/ijms23158101
APA Style
Feldheim, J., Wend, D., Lauer, M. J., Monoranu, C. M., Glas, M., Kleinschnitz, C., Ernestus, R. -I., Braunger, B. M., Meybohm, P., Hagemann, C., & Burek, M.
(2022). Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients. International Journal of Molecular Sciences, 23(15), 8101.
https://doi.org/10.3390/ijms23158101
